-
1
Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression
Published 2021“…American Society of Hematology…”
Conference item -
2
Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme R...
Published 2016“…American Society of Hematology…”
Conference item -
3
A novel model of human hemopoiesis based on single cell functional and transcriptional analysis of lympho-myeloid progenitors
Published 2017“…American Society of Hematology…”
Conference item -
4
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
Published 2016“…American Society of Hematology…”
Journal article -
5
Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
Published 2017“…American Society of Hematology…”
Conference item -
6
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia
Published 2020“…American Society of Hematology…”
Journal article -
7
Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis
Published 2018“…American Society of Hematology…”
Conference item -
8
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Published 2017“…American Society of Hematology…”
Journal article